Physical activity coaching in patients with interstitial lung diseases: A randomized controlled trial
Jazyk angličtina Země Velká Británie, Anglie Médium print
Typ dokumentu randomizované kontrolované studie, časopisecké články
PubMed
38511242
PubMed Central
PMC10956148
DOI
10.1177/14799731241235231
Knihovny.cz E-zdroje
- Klíčová slova
- Physical activity, interstitial lung disease, telecoaching,
- MeSH
- cvičení MeSH
- intersticiální plicní nemoci * terapie MeSH
- kvalita života MeSH
- lidé MeSH
- mentoring * MeSH
- průzkumy a dotazníky MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- randomizované kontrolované studie MeSH
OBJECTIVES: Physical activity is reduced in patients with interstitial lung disease (ILD) and physical inactivity is related to poor health outcomes. We investigated the effect of a telecoaching intervention to improve physical activity in patients with ILD. METHODS: Eighty patients with ILD were randomized into the intervention or control group. Patients in the intervention group received a 12-week telecoaching program including a step counter, a patient-tailored smartphone application, and coaching calls. Patients in the control group received usual care. Physical activity (primary outcome), physical fitness and quality of life were measured at baseline and 12 weeks later with an accelerometer, 6-min walking test and quadriceps muscle force and the King's Brief Interstitial Lung Disease questionnaire (K-BILD). RESULTS: Participation in telecoaching did not improve physical activity: between-group differences for step count: 386 ± 590 steps/day, p = .52; sedentary time: 4 ± 18 min/day, p = .81; movement intensity: 0.04 ± 0.05 m/s2, p = .45). Between-group differences for the 6-min walking test, quadriceps muscle force and K-BILD were 14 ± 10 m, p = .16; 2 ± 3% predicted, p = .61; 0.8 ± 1.7 points, p = .62 respectively. CONCLUSIONS: Twelve weeks of telecoaching did not improve physical activity, physical fitness or quality of life in patients with ILD. Future physical or behavioural interventions are needed for these patients to improve physical activity.
BREATHE Department CHROMETA KU Leuven Leuven Belgium
Clinical Department of Respiratory Diseases University Hospitals Leuven Leuven Belgium
Department of Pulmonary Diseases and Tuberculosis University Hospital Olomouc Olomouc Czech Republic
Department of Rehabilitation Sciences Ghent University Ghent Belgium
Department of Rehabilitation Sciences KU Leuven Leuven Belgium
Faculty of Medicine Palacký University Olomouc Czech Republic
Zobrazit více v PubMed
Martin Ginis KA, van der Ploeg HP, Foster C, et al. Participation of people living with disabilities in physical activity: a global perspective. Lancet 2021; 398(10298): 443–455. PubMed
Wallaert B, Monge E, Le Rouzic O, et al. Physical activity in daily life of patients with fibrotic idiopathic interstitial pneumonia. Chest 2013; 144(5): 1652–1658. PubMed
Cho PSP, Vasudevan S, Maddocks M, et al. Physical inactivity in pulmonary sarcoidosis. Lung 2019; 197(3): 285–293. PubMed PMC
Dale MT, McKeough ZJ, Munoz PA, et al. Physical activity in people with asbestos related pleural disease and dust-related interstitial lung disease: an observational study. Chron Respir Dis 2015; 12(4): 291–298. PubMed
Breuls S, Pereira de Araujo C, Blondeel A, et al. Physical activity pattern of patients with interstitial lung disease compared to patients with COPD: a propensity-matched study. PLoS One 2022; 17(11): e0277973. PubMed PMC
Bahmer T, Kirsten AM, Waschki B, et al. Prognosis and longitudinal changes of physical activity in idiopathic pulmonary fibrosis. BMC Pulm Med 2017; 17(1): 104. PubMed PMC
Bahmer T, Kirsten AM, Waschki B, et al. Clinical correlates of reduced physical activity in idiopathic pulmonary fibrosis. Respiration 2016; 91(6): 497–502. PubMed
Rocha V, Paixão C, Marques A. Physical activity, exercise capacity and mortality risk in people with interstitial lung disease: a systematic review and meta-analysis. J Sci Med Sport 2022; 25: 903–910. PubMed
Spruit MA, Singh SJ, Garvey C, ATS/ERS Task Force on Pulmonary Rehabilitation , et al. An official American thoracic society/European respiratory society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med 2013; 188(8): e13–64. PubMed
Perez-Bogerd S, Wuyts W, Barbier V, et al. Short and long-term effects of pulmonary rehabilitation in interstitial lung diseases: a randomised controlled trial. Respir Res 2018; 19(1): 182. PubMed PMC
Jarosch I, Schneeberger T, Gloeckl R, et al. Short-term effects of comprehensive pulmonary rehabilitation and its maintenance in patients with idiopathic pulmonary fibrosis: a randomized controlled trial. J Clin Med 2020; 9(5): 1567. PubMed PMC
Dale MT, McKeough ZJ, Munoz PA, et al. Exercise training for asbestos-related and other dust-related respiratory diseases: a randomised controlled trial. BMC Pulm Med 2014; 14: 180. PubMed PMC
Cerdán-de-Las-Heras J, Balbino F, Løkke A, et al. Tele-rehabilitation program in idiopathic pulmonary fibrosis-a single-center randomized trial. Int J Environ Res Publ Health 2021; 18(19): 10016. PubMed PMC
Blondeel A, Demeyer H, Janssens W, et al. The role of physical activity in the context of pulmonary rehabilitation. COPD 2018; 15(6): 632–639. PubMed
Armstrong M, Winnard A, Chynkiamis N, et al. Use of pedometers as a tool to promote daily physical activity levels in patients with COPD: a systematic review and meta-analysis. Eur Respir Rev 2019; 28(154): 190039. PubMed PMC
Sze WT, Waki K, Enomoto S, et al. StepAdd: a personalized mHealth intervention based on social cognitive theory to increase physical activity among type 2 diabetes patients. J Biomed Inf 2023; 145: 104481. PubMed
Duff OM, Walsh DM, Furlong BA, et al. Behavior change techniques in physical activity eHealth interventions for people with cardiovascular disease: systematic review. J Med Internet Res 2017; 19(8): e281. PubMed PMC
Samdal GB, Eide GE, Barth T, et al. Effective behaviour change techniques for physical activity and healthy eating in overweight and obese adults; systematic review and meta-regression analyses. Int J Behav Nutr Phys Activ 2017; 14(1): 42. PubMed PMC
Wijsenbeek M, Suzuki A, Maher TM. Interstitial lung diseases. Lancet 2022; 400(10354): 769–786. PubMed
Schulz KF, Altman DG, Moher D, CONSORT Group . CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. Trials 2010; 11: 32. PubMed
Travis WD, Costabel U, Hansell DM, ATS/ERS Committee on Idiopathic Interstitial Pneumonias , et al. An official American thoracic society/European respiratory society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2013; 188(6): 733–748. PubMed PMC
Demeyer H, Louvaris Z, Frei A, Mr Papp PROactive Study Group and the PROactive Consortium , et al. Physical activity is increased by a 12-week semiautomated telecoaching programme in patients with COPD: a multicentre randomised controlled trial. Thorax 2017; 72(5): 415–423. PubMed PMC
Michie S, van Stralen MM, West R. The behaviour change wheel: a new method for characterising and designing behaviour change interventions. Implement Sci 2011; 6: 42. PubMed PMC
Loeckx M, Rodrigues FM, Blondeel A, et al. Sustaining training effects through physical activity coaching (STEP): a randomized controlled trial. Int J Behav Nutr Phys Activ 2023; 20(1): 121. PubMed PMC
Van Remoortel H, Raste Y, Louvaris Z, PROactive Consortium , et al. Validity of six activity monitors in chronic obstructive pulmonary disease: a comparison with indirect calorimetry. PLoS One 2012; 7(6): e39198. PubMed PMC
Demeyer H, Mohan D, Burtin C, Chronic Lung Disease Biomarker and Clinical Outcome Assessment Qualification Consortium Task Force on Physical Activity , et al. Objectively measured physical activity in patients with COPD: recommendations from an international task force on physical activity. Chronic Obstr Pulm Dis 2021; 8: 528–550. PubMed PMC
Demeyer H, Burtin C, Hornikx M, et al. The minimal important difference in physical activity in patients with COPD. PLoS One 2016; 11(4): e0154587. PubMed PMC
Miller MR, Hankinson J, Brusasco V, ATS/ERS Task Force , et al. Standardisation of spirometry. Eur Respir J 2005; 26(2): 319–338. PubMed
Wanger J, Clausen JL, Coates A, et al. Standardisation of the measurement of lung volumes. Eur Respir J 2005; 26(3): 511–522. PubMed
Macintyre N, Crapo RO, Viegi G, et al. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J 2005; 26(4): 720–735. PubMed
Holland AE, Spruit MA, Troosters T, et al. An official European respiratory society/American thoracic society technical standard: field walking tests in chronic respiratory disease. Eur Respir J 2014; 44(6): 1428–1446. PubMed
Quanjer PH, Tammeling GJ, Cotes JE, et al. Lung volumes and forced ventilatory flows. Eur Respir J 1993; 6(Suppl 16): 5–40. PubMed
Gosselink R, Troosters T, Decramer M. Peripheral muscle weakness contributes to exercise limitation in COPD. Am J Respir Crit Care Med 1996; 153(3): 976–980. PubMed
Loeckx M, Rabinovich RA, Demeyer H, et al. Smartphone-based physical activity telecoaching in chronic obstructive pulmonary disease: mixed-methods study on patient experiences and lessons for implementation. JMIR 2018; 6(12): e200. PubMed PMC
Kang M, Veeraraghavan S, Martin GS, et al. An updated approach to determine minimal clinically important differences in idiopathic pulmonary fibrosis. ERJ Open Res 2021; 7(4): 00142. PubMed PMC
Pudkasam S, Feehan J, Talevski J, et al. Motivational strategies to improve adherence to physical activity in breast cancer survivors: a systematic review and meta-analysis. Maturitas 2021; 152: 32–47. PubMed
Wunsch K, Kienberger K, Niessner C. Changes in physical activity patterns due to the covid-19 pandemic: a systematic review and meta-analysis. Int J Environ Res Publ Health 2022; 19(4): 2250. PubMed PMC
Spielmanns M, Boeselt T, Huber S, et al. Impact of a smartphone application (KAIA COPD app) in combination with activity monitoring as a maintenance program following pulmonary rehabilitation in COPD: the protocol for the AMOPUR study, an international, multicenter, parallel group, randomized, controlled study. Trials 2020; 21(1): 636. PubMed PMC